Heparin cofactor II

Heparin cofactor II

Heparin cofactor II, a protein encoded by the SERPIND1 gene, is a coagulation factor that inhibits IIa, and is a cofactor for heparin and dermatan sulfate ("minor antithrombin"). cite web | title = Entrez Gene: SERPIND1 serpin peptidase inhibitor, clade D (heparin cofactor), member 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3053| accessdate = ]

PBB_Summary
section_title =
summary_text = The product encoded by this gene is a serine proteinase inhibitor which rapidly inhibits thrombin in the presence of dermatan sulfate or heparin. The gene contains five exons and four introns. This protein shares homology with antithrombin III and other members of the alpha 1-antitrypsin superfamily. Mutations in this gene are associated with heparin cofactor II deficiency.cite web | title = Entrez Gene: SERPIND1 serpin peptidase inhibitor, clade D (heparin cofactor), member 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3053| accessdate = ] Heparin Cofactor II deficiency can lead to increased thrombin generation and a hypercoagulable state.

References

Further reading

PBB_Further_reading
citations =
*cite journal | author=Pizzo SV |title=Serpin receptor 1: a hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes. |journal=Am. J. Med. |volume=87 |issue= 3B |pages= 10S–14S |year= 1989 |pmid= 2552799 |doi=
*cite journal | author=Uszyński M |title=Tissue anticoagulants in the human placenta: preliminary study with a heparin-like anticoagulant and review of the literature. |journal=Gynecol. Obstet. Invest. |volume=32 |issue= 3 |pages= 129–33 |year= 1992 |pmid= 1836773 |doi=
*cite journal | author=Sutherland JS, Bhakta V, Filion ML, Sheffield WP |title=The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition. |journal=Biochemistry |volume=45 |issue= 38 |pages= 11444–52 |year= 2006 |pmid= 16981704 |doi= 10.1021/bi0609624
*cite journal | author=Giri TK, Tollefsen DM |title=Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II. |journal=Blood |volume=107 |issue= 7 |pages= 2753–8 |year= 2006 |pmid= 16339402 |doi= 10.1182/blood-2005-09-3755
*cite journal | author=Liu T, Qian WJ, Gritsenko MA, "et al." |title=Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. |journal=J. Proteome Res. |volume=4 |issue= 6 |pages= 2070–80 |year= 2006 |pmid= 16335952 |doi= 10.1021/pr0502065
*cite journal | author=Rual JF, Venkatesan K, Hao T, "et al." |title=Towards a proteome-scale map of the human protein-protein interaction network. |journal=Nature |volume=437 |issue= 7062 |pages= 1173–8 |year= 2005 |pmid= 16189514 |doi= 10.1038/nature04209
*cite journal | author=Schillinger M, Exner M, Sabeti S, "et al." |title=High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting. |journal=Thromb. Haemost. |volume=92 |issue= 5 |pages= 1108–13 |year= 2005 |pmid= 15543340 |doi= 10.1267/THRO04051108
*cite journal | author=Collins JE, Wright CL, Edwards CA, "et al." |title=A genome annotation-driven approach to cloning the human ORFeome. |journal=Genome Biol. |volume=5 |issue= 10 |pages= R84 |year= 2005 |pmid= 15461802 |doi= 10.1186/gb-2004-5-10-r84
*cite journal | author=Suzuki Y, Yamashita R, Shirota M, "et al." |title=Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions. |journal=Genome Res. |volume=14 |issue= 9 |pages= 1711–8 |year= 2004 |pmid= 15342556 |doi= 10.1101/gr.2435604
*cite journal | author=Corral J, Aznar J, Gonzalez-Conejero R, "et al." |title=Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis. |journal=Circulation |volume=110 |issue= 10 |pages= 1303–7 |year= 2006 |pmid= 15337701 |doi= 10.1161/01.CIR.0000140763.51679.D9
*cite journal | author=Fortenberry YM, Whinna HC, Gentry HR, "et al." |title=Molecular mapping of the thrombin-heparin cofactor II complex. |journal=J. Biol. Chem. |volume=279 |issue= 41 |pages= 43237–44 |year= 2004 |pmid= 15292227 |doi= 10.1074/jbc.M406716200
*cite journal | author=Zhang F, Wu Y, Ma Q, "et al." |title=Studies on the effect of calcium in interactions between heparin and heparin cofactor II using surface plasmon resonance. |journal=Clin. Appl. Thromb. Hemost. |volume=10 |issue= 3 |pages= 249–57 |year= 2004 |pmid= 15247982 |doi=
*cite journal | author=Anderson NL, Polanski M, Pieper R, "et al." |title=The human plasma proteome: a nonredundant list developed by combination of four separate sources. |journal=Mol. Cell Proteomics |volume=3 |issue= 4 |pages= 311–26 |year= 2004 |pmid= 14718574 |doi= 10.1074/mcp.M300127-MCP200
*cite journal | author=Strausberg RL, Feingold EA, Grouse LH, "et al." |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899
*cite journal | author=Noda A, Wada H, Kusiya F, "et al." |title=Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation. |journal=Clin. Appl. Thromb. Hemost. |volume=8 |issue= 3 |pages= 265–71 |year= 2003 |pmid= 12361205 |doi=
*cite journal | author=Baglin TP, Carrell RW, Church FC, "et al." |title=Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 17 |pages= 11079–84 |year= 2002 |pmid= 12169660 |doi= 10.1073/pnas.162232399
*cite journal | author=Cunningham MA, Bhakta V, Sheffield WP |title=Altering heparin cofactor II at VAL439 (P6) either impairs inhibition of thrombin or confers elastase resistance. |journal=Thromb. Haemost. |volume=88 |issue= 1 |pages= 89–97 |year= 2003 |pmid= 12152684 |doi=
*cite journal | author=Hayakawa Y, Hirashima Y, Kurimoto M, "et al." |title=Contribution of basic residues of the A helix of heparin cofactor II to heparin- or dermatan sulfate-mediated thrombin inhibition. |journal=FEBS Lett. |volume=522 |issue= 1-3 |pages= 147–50 |year= 2002 |pmid= 12095635 |doi=
*cite journal | author=Mitchell JW, Church FC |title=Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition. |journal=J. Biol. Chem. |volume=277 |issue= 22 |pages= 19823–30 |year= 2002 |pmid= 11856753 |doi= 10.1074/jbc.M200630200
*cite journal | author=Böhme C, Nimtz M, Grabenhorst E, "et al." |title=Tyrosine sulfation and N-glycosylation of human heparin cofactor II from plasma and recombinant Chinese hamster ovary cells and their effects on heparin binding. |journal=Eur. J. Biochem. |volume=269 |issue= 3 |pages= 977–88 |year= 2002 |pmid= 11846800 |doi=

External links

*
*

PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = yes


Wikimedia Foundation. 2010.

Игры ⚽ Поможем решить контрольную работу

Look at other dictionaries:

  • heparin cofactor II — a member of the serpin group, a single chain glycoprotein, Mr 65,000, that inhibits thrombin. It resembles antithrombin III in being markedly stimulated by heparin; it differs in that it binds and is activated by dermatan sulfate and in that it… …   Medical dictionary

  • Heparin — An anticoagulant (anti clotting) medication. Heparin is useful in preventing thromboembolic complications (clots that travel from their site of origin through the blood stream to clog up another vessel). Heparin is also used in the early… …   Medical dictionary

  • Antithrombin — Serpin peptidase inhibitor, clade C (antithrombin), member 1 Antithrombin monomer drawn from PDB 2ANT …   Wikipedia

  • Coagulation — This article is about blood clotting. For other meanings see Coagulation (disambiguation). Coagulation is a complex process by which blood forms clots. It is an important part of hemostasis, the cessation of blood loss from a damaged vessel,… …   Wikipedia

  • Serpin — Serpins are a group of proteins with similar structures that were first identified as a set of proteins able to inhibit proteases. The name serpin is derived from this activity serine protease inhibitors. [cite journal |author=R. Carrell and J.… …   Wikipedia

  • Factor H — Complement factor H PDB rendering based on 1haq …   Wikipedia

  • bleeding and blood clotting — ▪ disease Introduction       escape of blood from blood vessels into surrounding tissue and the process of coagulation through the action of platelets. Significance of hemostasis       The evolution of high pressure blood circulation in… …   Universalium

  • Fibronectin — 1 PDB rendering based on 1e88 …   Wikipedia

  • Thrombin — Coagulation factor II (thrombin) The structure of human thrombin in complex with the inhibitor hirudin.[1] …   Wikipedia

  • Transcortin — Serpin peptidase inhibitor, clade A (alpha 1 antiproteinase, antitrypsin), member 6, also Corticosteroid Binding Globulin or Transcortin Structure of corticosteroid binding globulin in complex with cortisol. Identifiers Symbol SE …   Wikipedia

Share the article and excerpts

Direct link
… Do a right-click on the link above
and select “Copy Link”